Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Home > Investor Relations > Corporate Governance > Code of Ethics

Code of Ethics

On June 19, 2008, our Board of Directors amended our Code of Business Conduct and Ethics to reflect promotional and marketing policies we adopted due to the FDA's approval of the new drug application for our drug product, Fusilev(tm). Additional non-substantive changes of a technical and administrative nature were also made . A copy of the amended Code will be provided to any person, without charge, upon oral request to (702) 835-6300 or upon written request to Investor Relations, Spectrum Pharmaceuticals, Inc., 11500 S. Eastern Ave, Suite 240, Henderson, NV 89052.


PDF Download PDF   7.9 KB   Add to Briefcase

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

NASDAQ: SPPI

Price:
8.12
Change:
+ 0.08
Day High:
8.21
Day Low:
8.07
Volume:
696,977
4:00 PM ET on Jul 21, 2017
Delayed at least 20 minutes.
Provided by eSignal.

Shareholder Tools

Print Email

Search IR